Cx Precision Medicine, Inc. announced it raised $934,000 in an initial filing from an offering of $1.3 Million

Company

Location

About

Cx Precision Medicine is a life science company developing blood-based biomarker screening technology as well as companion diagnostics for therapeutic agents. Our lead products are focused on neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, and other dementia-causing disorders. Our low-cost and non-invasive tests will rule out Alzheimer’s disease and Parkinson’s disease for many and help identify others who will benefit from more comprehensive testing. Our test will also help physicians treat patients with the right medicines more quickly.